sorry, we can't preview this file
pone.0298420.s001.docx (15.33 kB)
The occurrence of ADRsa that lead to treatment discontinuation (n = 703).
journal contribution
posted on 2024-03-08, 18:26 authored by Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji FuruseaThe proportion of ADRs ≥1% are presented in the table. ADR, adverse drug reaction; HFSR, hand-foot skin reaction.
(DOCX)
History
Usage metrics
Categories
Keywords
unresectable hepatocellular carcinomaprospective cohort studyobjective response ratemarketing surveillance studydisease control ratebetter performance statusbetter overall conditionsbetter modified albuminadverse drug reactionsrelative dose intensityphysician &# 8217na &# 239treatment group oftenmedian treatment durationterm lenvatinib treatmentlonger treatment tendedlonger treatment periodlenvatinib dose modificationsinitial 177 dayshoc analysis aimede ., rditwo treatment groupstreatment (& ltjapan 2 %; pshorter treatment grouptreatment grouptreatment durationhoc analysis177 daystreatment outcomestreatment groupsdose modification&# 8805significantly higherpugh scoremay contributelower childjuly 2018january 2019high regardlessgenerally similarfully understooddichotomized usingbilirubin grade12 months(&# 8805
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC